Evidence map›Paper›PMID 29403152›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2018

Adrenocortical carcinoma characterized by gynecomastia: A case report.

Takako Takeuchi, Yuko Yoto, Akira Ishii, Takeshi Tsugawa, Masaki Yamamoto, Tsukasa Hori, Hotaka Kamasaki, Kazutaka Nogami, Takanori Oda, Akihiro Nui and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Adrenocortical carcinoma: Pediatric aspects (Review).Experimental and therapeutic medicine · 2022
    Review
  4. Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual PseudopubertyJournal of clinical research in pediatric endocrinology · 2022
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Takako TakeuchiDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yuko YotoDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Akira IshiiDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Takeshi TsugawaDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Masaki YamamotoDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Tsukasa HoriDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Hotaka KamasakiDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kazutaka NogamiDepartment of Pediatrics Hematology and Oncology, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
Takanori OdaDepartment of Pediatrics Hematology and Oncology, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
Akihiro NuiDepartment of Pediatric Surgery, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
Sachiko KimuraDepartment of Pathology, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
Takuya YamagishiMaternal-Child Screening Division, Health Science Section, Sapporo City Institute of Public Health, Sapporo, Japan.
Keiko HommaClinical Laboratory, Keio University Hospital, Tokyo, Japan.
Tomonobu HasegawaDepartment of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Maki FukamiDepartment of Molecular Endocrinology, National Center for Child Health and Development, Tokyo, Japan.
Yoko WatanabeInspection Department, ASKA Pharma Medical Co., Ltd, Kawasaki, Japan.
Hidehiko SasamotoInspection Department, ASKA Pharma Medical Co., Ltd, Kawasaki, Japan.
Hiroyuki TsutsumiDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Sapporo Medical University · JPNational Hospital Organization Hokkaido Medical Center · JPASKA Pharmaceutical (Japan) · JPHokkaido Institute of Public Health · JPKeio University · JPKeio University Hospital · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a 4-yr-old boy with adrenocortical carcinoma (ACC), diagnosed due to the appearance of gynecomastia as the presenting symptom. Six months prior to admission, an acute growth spurt along with the development of bilateral breast swelling was observed. He did not present any features of virilization, including enlargement of the testes, increase in testis volume, and penis size. Laboratory investigations showed gonadotropin-independent hypergonadism, with low LH/ FSH levels and elevated estradiol/testosterone levels. Abdominal computed tomography revealed a large heterogeneous mass adjacent to the right kidney and below the liver. Pathological investigations of the biopsy specimen demonstrated that the tumor was an ACC. Pre- and post-operative combination chemotherapy with mitotane was administered and surgical resection was carried out. Post-surgery, the elevated estradiol/testosterone concentrations reverted to within the reference range. Urinary steroid profile and tissue concentration analysis of estradiol and testosterone indicated the presence of estrogen in the ACC tissue. An investigation for

Indexed as

adrenocortical carcinomagynecomastiaTP53

Identifiers

PMID29403152
PMCPMC5792817
OpenAlexW2794411672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.